BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 38732512)

  • 1. Influence of Dietary Polyunsaturated Fatty Acid Intake on Potential Lipid Metabolite Diagnostic Markers in Renal Cell Carcinoma: A Case-Control Study.
    Kim YH; Chung JS; Lee HH; Park JH; Kim MK
    Nutrients; 2024 Apr; 16(9):. PubMed ID: 38732512
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Global and targeted metabolomics of esophageal squamous cell carcinoma discovers potential diagnostic and therapeutic biomarkers.
    Xu J; Chen Y; Zhang R; Song Y; Cao J; Bi N; Wang J; He J; Bai J; Dong L; Wang L; Zhan Q; Abliz Z
    Mol Cell Proteomics; 2013 May; 12(5):1306-18. PubMed ID: 23397110
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of C26:0-lysophosphatidylcholine and C26:0-carnitine as diagnostic markers for Zellweger spectrum disorders.
    Klouwer FCC; Ferdinandusse S; van Lenthe H; Kulik W; Wanders RJA; Poll-The BT; Waterham HR; Vaz FM
    J Inherit Metab Dis; 2017 Nov; 40(6):875-881. PubMed ID: 28677031
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Macronutrients, fatty acids, cholesterol and renal cell cancer risk.
    Bidoli E; Talamini R; Zucchetto A; Polesel J; Bosetti C; Negri E; Maruzzi D; Montella M; Franceschi S; La Vecchia C
    Int J Cancer; 2008 Jun; 122(11):2586-9. PubMed ID: 18224688
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Urine metabolomic analysis in clear cell and papillary renal cell carcinoma: A pilot study.
    Oto J; Fernández-Pardo Á; Roca M; Plana E; Solmoirago MJ; Sánchez-González JV; Vera-Donoso CD; Martínez-Sarmiento M; España F; Navarro S; Medina P
    J Proteomics; 2020 Apr; 218():103723. PubMed ID: 32126320
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasma Glycosaminoglycans as Diagnostic and Prognostic Biomarkers in Surgically Treated Renal Cell Carcinoma.
    Gatto F; Blum KA; Hosseini SS; Ghanaat M; Kashan M; Maccari F; Galeotti F; Hsieh JJ; Volpi N; Hakimi AA; Nielsen J
    Eur Urol Oncol; 2018 Oct; 1(5):364-377. PubMed ID: 31158075
    [TBL] [Abstract][Full Text] [Related]  

  • 7. UPLC-MS based urine untargeted metabolomic analyses to differentiate bladder cancer from renal cell carcinoma.
    Wang Z; Liu X; Liu X; Sun H; Guo Z; Zheng G; Zhang Y; Sun W
    BMC Cancer; 2019 Dec; 19(1):1195. PubMed ID: 31805976
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification and validation of novel prognostic markers in Renal Cell Carcinoma.
    Rabjerg M
    Dan Med J; 2017 Oct; 64(10):. PubMed ID: 28975890
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lipid metabolism reprogramming in renal cell carcinoma.
    Heravi G; Yazdanpanah O; Podgorski I; Matherly LH; Liu W
    Cancer Metastasis Rev; 2022 Mar; 41(1):17-31. PubMed ID: 34741716
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of dietary n-3 and n-6 polyunsaturated fatty acids on lipid-metabolizing enzymes in obese rat liver.
    Niot I; Gresti J; Boichot J; Semporé G; Durand G; Bézard J; Clouet P
    Lipids; 1994 Jul; 29(7):481-9. PubMed ID: 7968269
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lipid Profile Modulates Cardiometabolic Risk Biomarkers Including Hypertension in People with Type-2 Diabetes: A Focus on Unbalanced Ratio of Plasma Polyunsaturated/Saturated Fatty Acids.
    Gouaref I; Bouazza A; Abderrhmane SA; Koceir EA
    Molecules; 2020 Sep; 25(18):. PubMed ID: 32962299
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Circulating miR-378 and miR-451 in serum are potential biomarkers for renal cell carcinoma.
    Redova M; Poprach A; Nekvindova J; Iliev R; Radova L; Lakomy R; Svoboda M; Vyzula R; Slaby O
    J Transl Med; 2012 Mar; 10():55. PubMed ID: 22440013
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Krill oil reduces plasma triacylglycerol level and improves related lipoprotein particle concentration, fatty acid composition and redox status in healthy young adults - a pilot study.
    Berge RK; Ramsvik MS; Bohov P; Svardal A; Nordrehaug JE; Rostrup E; Bruheim I; Bjørndal B
    Lipids Health Dis; 2015 Dec; 14():163. PubMed ID: 26666303
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of C26:0-carnitine and C26:0-lysophosphatidylcholine as diagnostic markers in dried blood spots from newborns and patients with adrenoleukodystrophy.
    Huffnagel IC; van de Beek MC; Showers AL; Orsini JJ; Klouwer FCC; Dijkstra IME; Schielen PC; van Lenthe H; Wanders RJA; Vaz FM; Morrissey MA; Engelen M; Kemp S
    Mol Genet Metab; 2017 Dec; 122(4):209-215. PubMed ID: 29089175
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dietary intake and plasma metabolomic analysis of polyunsaturated fatty acids in bipolar subjects reveal dysregulation of linoleic acid metabolism.
    Evans SJ; Ringrose RN; Harrington GJ; Mancuso P; Burant CF; McInnis MG
    J Psychiatr Res; 2014 Oct; 57():58-64. PubMed ID: 24953860
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Value of global metabolomics in association with diagnosis and clinicopathological factors of renal cell carcinoma.
    Sato T; Kawasaki Y; Maekawa M; Takasaki S; Saigusa D; Ota H; Shimada S; Yamashita S; Mitsuzuka K; Yamaguchi H; Ito A; Kinoshita K; Koshiba S; Mano N; Arai Y
    Int J Cancer; 2019 Jul; 145(2):484-493. PubMed ID: 30628065
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Discovery and validation of urinary biomarkers for detection of renal cell carcinoma.
    Frantzi M; Metzger J; Banks RE; Husi H; Klein J; Dakna M; Mullen W; Cartledge JJ; Schanstra JP; Brand K; Kuczyk MA; Mischak H; Vlahou A; Theodorescu D; Merseburger AS
    J Proteomics; 2014 Feb; 98():44-58. PubMed ID: 24374379
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of pro-MMP-7 as a serum marker for renal cell carcinoma by use of proteomic analysis.
    Sarkissian G; Fergelot P; Lamy PJ; Patard JJ; Culine S; Jouin P; Rioux-Leclercq N; Darbouret B
    Clin Chem; 2008 Mar; 54(3):574-81. PubMed ID: 18202161
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preoperative Lymphocyte-Monocyte Ratio Ameliorates the Accuracy of Differential Diagnosis in Non-Metastatic Infiltrative Renal Masses.
    Han JH; Yoon YE; Kim SY; Cho YI; Rha KH; Choi YD; Han WK
    Yonsei Med J; 2017 Mar; 58(2):388-394. PubMed ID: 28120570
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of miR-20a-5p as Robust Normalizer for Urine microRNA Studies in Renal Cell Carcinoma and a Profile of Dysregulated microRNAs.
    Oto J; Herranz R; Plana E; Sánchez-González JV; Pérez-Ardavín J; Hervás D; Fernández-Pardo Á; Cana F; Vera-Donoso CD; Martínez-Sarmiento M; Medina P
    Int J Mol Sci; 2021 Jul; 22(15):. PubMed ID: 34360679
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.